May 2020 - Evolution Biotechnologies
archive,date,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-16.4,qode-theme-bridge,wpb-js-composer js-comp-ver-5.4.7,vc_responsive

Bedford, UK, and Beijing, China – May 23rd 2020 Evolution Biotechnologies (, the UK-based company pioneering the use of biological control to benefit human health, announced that on May 20th 2020, the UK Government launched an innovative new funding programme to support early-stage companies with a £250 million convertible loan matching fund, The Future Fund. The Future Fund is open to companies that: are incorporated in the UK; have raised at least £250,000 in equity investment from third-party investors in the last 5 years are not publicly listed were incorporated on or before 31 December 2019; and at least half of its...